Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

NEUROLOGISK KLINIK ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   4.7% 5.1% 3.4% 5.6% 4.1% 5.1% 12.2% 12.0%   Credit score (0-100)   47 45 56 41 48 43 18 20   Credit rating   BBB BBB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   202 89.1 259 161 259 100 0.0 0.0   EBITDA   202 89.1 259 319 259 100 0.0 0.0   EBIT   138 25.1 195 240 259 100 0.0 0.0   Pre-tax profit (PTP)   128.7 16.9 185.8 250.8 897.5 343.9 0.0 0.0   Net earnings   100.4 13.2 144.7 194.6 699.8 265.9 0.0 0.0   Pre-tax profit without non-rec. items   129 16.9 186 251 898 344 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Tangible assets total   200 136 72.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   363 376 521 863 1,450 1,716 1,591 1,591   Interest-bearing liabilities   225 210 239 0.0 102 290 0.0 0.0   Balance sheet total (assets)   676 648 892 1,027 1,919 2,290 1,591 1,591   Net Debt   -220 -277 -537 -994 -1,787 -2,001 -1,591 -1,591     See the entire balance sheet 1000.0 Volume  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   202 89.1 259 161 259 100 0.0 0.0   Gross profit growth   80.8% -55.8% 190.6% -38.0% 61.2% -61.4% -100.0% 0.0%   Employees   0 0 0 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   676 648 892 1,027 1,919 2,290 1,591 1,591   Balance sheet change%   14.1% -4.1% 37.7% 15.2% 86.8% 19.4% -30.5% 0.0%   Added value   201.7 89.1 258.9 318.6 337.8 100.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -128 -128 -128 -151 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   68.3% 28.2% 75.3% 149.2% 100.0% 100.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   21.7% 3.8% 25.3% 26.6% 61.1% 16.9% 0.0% 0.0%   ROI %   23.9% 4.2% 28.8% 31.5% 74.6% 20.0% 0.0% 0.0%   ROE %   32.1% 3.6% 32.3% 28.1% 60.5% 16.8% 0.0% 0.0%   1000.0 Solidity  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Equity ratio %   53.7% 58.0% 58.4% 84.0% 75.6% 74.9% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -109.0% -310.4% -207.3% -312.1% -690.5% -2,001.7% 0.0% 0.0%   Gearing %   61.9% 55.9% 45.8% 0.0% 7.0% 16.9% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   3.7% 3.8% 4.0% 3.8% 5.5% 6.4% 0.0% 0.0%   1000.0 Liquidity  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Quick Ratio   1.6 1.9 2.2 6.3 4.1 4.0 0.0 0.0   Current Ratio   1.6 1.9 2.2 6.3 4.1 4.0 0.0 0.0   Cash and cash equivalent   444.5 486.9 775.3 994.4 1,888.6 2,290.5 0.0 0.0   1000.0 Capital use efficiency  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   179.0 245.8 448.7 634.5 -122.8 -96.9 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0